Cover Image
Market Research Report
Product code 
357504

Sicca Syndrome (Sjogren) Global Clinical Trials Review, H2, 2019

Published: | GlobalData | 170 Pages | Delivery time: 1-2 business days

Price

Back to Top
Sicca Syndrome (Sjogren) Global Clinical Trials Review, H2, 2019
Published: December 9, 2019
GlobalData
Content info: 170 Pages
Delivery time: 1-2 business days
  • ALL
  • Description
  • Table of Contents
Description

GlobalData's clinical trial report, "Sicca Syndrome (Sjogren) Global Clinical Trials Review, H2, 2019" provides an overview of Sicca Syndrome (Sjogren) clinical trials scenario. This report provides top line data relating to the clinical trials on Sicca Syndrome (Sjogren) . Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents
Product Code: GDHC5177CTIDB

Table of Contents

  • List of Tables 4
  • List of Figures 5
  • Report Guidance 6
  • GlobalData Clinical Trials Report Coverage 7
  • Clinical Trials by Region 8
  • Clinical Trials and Average Enrollment by Country 9
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12
  • Top Five Countries Contributing to Clinical Trials in Europe 13
  • Top Countries Contributing to Clinical Trials in North America 14
  • Top Five Countries Contributing to Clinical Trials in Middle East and Africa 15
  • Top Five Countries Contributing to Clinical Trials in Central and South America 16
  • Clinical Trials by G7 Countries: Proportion of Sicca Syndrome (Sjogren) to Immunology Clinical Trials 17
  • Clinical Trials by Phase in G7 Countries 18
  • Clinical Trials in G7 Countries by Trial Status 19
  • Clinical Trials by E7 Countries: Proportion of Sicca Syndrome (Sjogren) to Immunology Clinical Trials 20
  • Clinical Trials by Phase in E7 Countries 21
  • Clinical Trials in E7 Countries by Trial Status 22
  • Clinical Trials by Phase 23
  • In Progress Trials by Phase 24
  • Clinical Trials by Trial Status 25
  • Clinical Trials by End Point Status 26
  • Subjects Recruited Over a Period of Time 27
  • Clinical Trials by Sponsor Type 28
  • Prominent Sponsors 29
  • Top Companies Participating in Sicca Syndrome (Sjogren) Therapeutics Clinical Trials 31
  • Prominent Drugs 32
  • Latest Clinical Trials News on Sicca Syndrome (Sjogren) 33
  • Nov 12, 2019: Alpine Immune Sciences presents new ALPN-101 preclinical data at the 2019 American College of Rheumatology (ACR) Annual Meeting 33
  • Nov 11, 2019: Encouraging Phase 2 data on cenerimod - Idorsia's S1P1 receptor modulator currently investigated for SLE - presented at ACR 2019 33
  • Oct 02, 2019: Alpine Immune Sciences announces upcoming scientific presentation of ALPN-101 at ACR/ARHP 2019 Annual Meeting 34
  • Oct 02, 2019: Data on cenerimod - Idorsia's S1P1 receptor modulator - will be presented at the ACR / ARP Annual Meeting 2019 34
  • Clinical Trial Profile Snapshots 36

Appendix 172

  • Abbreviations 172
  • Definitions 172
  • Research Methodology 173
  • Secondary Research 173
  • About GlobalData 174
  • Contact Us 174
  • Source 175

List of Tables

  • Sicca Syndrome (Sjogren) Therapeutics, Global, Clinical Trials by Region, 2019* 8
  • Sicca Syndrome (Sjogren) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 10
  • Sicca Syndrome (Sjogren) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 11
  • Sicca Syndrome (Sjogren) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2019* 12
  • Sicca Syndrome (Sjogren) Therapeutics Clinical Trials, Europe, Top Five Countries, 2019* 13
  • Sicca Syndrome (Sjogren) Therapeutics Clinical Trials, North America, Top Countries, 2019* 14
  • Sicca Syndrome (Sjogren) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2019* 15
  • Sicca Syndrome (Sjogren) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2019* 16
  • Proportion of Sicca Syndrome (Sjogren) to Immunology Clinical Trials, G7 Countries (%), 2019* 17
  • Sicca Syndrome (Sjogren) Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 18
  • Sicca Syndrome (Sjogren) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 19
  • Proportion of Sicca Syndrome (Sjogren) to Immunology Clinical Trials, E7 Countries (%), 2019* 20
  • Sicca Syndrome (Sjogren) Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 21
  • Sicca Syndrome (Sjogren) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 22
  • Sicca Syndrome (Sjogren) Therapeutics, Global, Clinical Trials by Phase, 2019* 23
  • Sicca Syndrome (Sjogren) Therapeutics, Global, Clinical Trials In Progress by Phase 2019* 24
  • Sicca Syndrome (Sjogren) Therapeutics, Global, Clinical Trials by Trial Status, 2019* 25
  • Sicca Syndrome (Sjogren) Therapeutics Clinical Trials, Global, by End Point Status, 2019* 26
  • Sicca Syndrome (Sjogren) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 27
  • Sicca Syndrome (Sjogren) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2019* 28
  • Sicca Syndrome (Sjogren) Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 30
  • Sicca Syndrome (Sjogren) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 31
  • Sicca Syndrome (Sjogren) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 32

List of Figures

  • Sicca Syndrome (Sjogren) Therapeutics, Global, Clinical Trials by Region (%), 2019* 8
  • Sicca Syndrome (Sjogren) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 9
  • Sicca Syndrome (Sjogren) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 11
  • Sicca Syndrome (Sjogren) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2019* 12
  • Sicca Syndrome (Sjogren) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2019* 13
  • Sicca Syndrome (Sjogren) Therapeutics Clinical Trials, North America, Top Countries (%), 2019* 14
  • Sicca Syndrome (Sjogren) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2019* 15
  • Sicca Syndrome (Sjogren) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2019* 16
  • Proportion of Sicca Syndrome (Sjogren) to Immunology Clinical Trials, G7 Countries (%), 2019* 17
  • Sicca Syndrome (Sjogren) Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 18
  • Sicca Syndrome (Sjogren) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 19
  • Proportion of Sicca Syndrome (Sjogren) to Immunology Clinical Trials, E7 Countries (%), 2019* 20
  • Sicca Syndrome (Sjogren) Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 21
  • Sicca Syndrome (Sjogren) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 22
  • Sicca Syndrome (Sjogren) Therapeutics, Global, Clinical Trials by Phase (%), 2019* 23
  • Sicca Syndrome (Sjogren) Therapeutics, Global, Clinical Trials In Progress by Phase, 2019* 24
  • Sicca Syndrome (Sjogren) Therapeutics, Global, Clinical Trials by Trial Status, 2019* 25
  • Sicca Syndrome (Sjogren) Therapeutics Clinical Trials, Global, by End Point Status, 2019* 26
  • Sicca Syndrome (Sjogren) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 27
  • Sicca Syndrome (Sjogren) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2019* 28
  • Sicca Syndrome (Sjogren) Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 29
  • Sicca Syndrome (Sjogren) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 31
  • Sicca Syndrome (Sjogren) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 32
  • GlobalData Methodology 173